HOME > Articles >

Korean J Gastroenterol  <  Volume 75(4); 2020 <  Articles

Korean J Gastroenterol 2020; 75(4): 228-230  https://doi.org/10.4166/kjg.2020.75.4.228
Could Preoperative Chemoradiotherapy Lead to the Survival Benefit of Patients with Resectable Pancreatic Cancer?
Yoon Suk Lee
Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea
Correspondence to: Yoon Suk Lee, Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, 170 Juhwa-ro, Ilsanseo-gu, Goyang 10380, Korea. Tel: +82-31-910-7797, Fax: +82-31-910-7219, E-mail: lys0326@paik.ac.kr, ORCID https://orcid.org/0000-0002-5835-9417
Published online: April 25, 2020.
© The Korean Journal of Gastroenterology. All rights reserved.

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


This Article


Author ORCID Information

Stats or Metrics
  • View: 70
  • Download: 44

Services
Social Network Service

e-submission

Archives

Official Journal of

Indexed/Covered by

  • thomson reuters
  • pubmedcentral
  • koreamed
  • crossref
  • crossref
  • synepse
  • kofst
  • DOAJ
  • ORCID